FibroBiologics to Present at JonesTrading Healthcare Summit 2024
15 Julio 2024 - 8:31AM
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a
clinical-stage biotechnology company with 150+ patents issued and
pending with a focus on the development of therapeutics and
potential cures for chronic diseases using fibroblasts and
fibroblast-derived materials, today announced that Founder and
Chief Executive Officer, Pete O’Heeron, will present at the
JonesTrading Healthcare Seaside Summit occurring July 14-16, 2024,
in San Diego, California.
Details of the presentations are as
follows:
Presentation Date: Monday, July
15, 2024Time: 1:45 p.m. PDTWebcast
Registration: https://wsw.com/webcast/jones/fblg/1793925
Links to the replay will be accessible under the “News &
Events” tab on the Investor Relations page on the company’s website
at https://ir.fibrobiologics.com/news-events/ir-calendar.
For more information, please visit
FibroBiologics' website or email FibroBiologics
at info@fibrobiologics.com.
About FibroBiologics
Based in Houston, FibroBiologics is a cell
therapy and regenerative medicine company developing a pipeline of
treatments and seeking potential cures for chronic diseases using
fibroblast cells and fibroblast-derived materials. FibroBiologics
holds 150+ US and internationally issued patents/patents pending
across various clinical pathways, including disc degeneration,
orthopedics, multiple sclerosis, wound healing, reversing organ
involution, and cancer. FibroBiologics represents the next
generation of medical advancement in cell therapy. For more
information, visit www.FibroBiologics.com.
General
Inquiries:info@fibrobiologics.com
Investor Relations:Nic
JohnsonRusso Partners212-845-4242fibrobiologicsIR@russopr.com
Media Contact:Liz PhillipsRusso
Partners(347) 956-7697Elizabeth.phillips@russopartnersllc.com
FibroBiologics (NASDAQ:FBLG)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
FibroBiologics (NASDAQ:FBLG)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024